Scholars Central

Conference abstractPublished 2018

Round table discussion on Treatment prospects for Alzheimers disease and dementia

Authors: Anthony Tsarbopoulos

National and Kapodistrian University of Athens Medical School, Greece

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Alzheimer’s disease (AD) is the most common cause of senile dementia in our ageing society, and it is characterized by a gradual and harmful decline in cognitive and non-cognitive function. AD is the fourth main causes of death affecting more than 35 million people worldwide whereas it is projected to almost quadruple by 2050. The pathogenesis of AD has not yet been clarified and the understanding of the disease mechanism remains elusive. Nevertheless, it is widely believed that abnormal accumulation and aggregation of disease- specific proteins lead to neurodegeneration. Over the last thirty years, there has been a remarkable progress in our knowledge of the disease underlying cause, which in turn has generated more insights into where and when we can intervene. Despite the immense research efforts that have been put over the past years on the characterization of AD and the development of disease-modifying therapeutic approaches, there is still no effective therapeutic for AD. Current drugs may temporarily improve the cognitive symptoms of Alzheimer's, thus helping people with AD to improve function and independence but do not treat the underlying disease or delay its progression. There are more than 120 drugs currently in clinical development for AD, targeting beta-amyloid (a protein that comprises the amyloid plaques), tau protein and other drug targets such as inflammation, mitochondria, and neuroprotection. An equally important factor to the success of preventive strategies is the discovery of biomarkers which will aid the identification of people at risk of AD but without evidence of significant neurodegeneration.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in International Journal of Mental Health & Psychiatry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Mental Health & Psychiatry
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Anthony Tsarbopoulos”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels